Julian Chavarriaga
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors: Erratum.
Journal: The Journal of urology
Published: June 09, 2026
Clinical Trials and Emerging Therapeutic Paradigms in Upper-Tract Urothelial Carcinoma.
Journal: Cancers
Published: March 19, 2026
Robotic versus open post-chemotherapy retroperitoneal lymph node dissection: a propensity score matched study across 11 academic medical centers.
Journal: World journal of urology
Published: February 10, 2026
Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors.
Journal: The Journal of urology
Published: November 10, 2025
Statin use and outcomes in advanced prostate cancer:Secondary analysis of the SPARTAN trial.
Journal: Urologic oncology
Published: November 02, 2025
MicroRNA as a Liquid Biomarker to Detect Malignancy in Small Testicular Masses.
Journal: European urology oncology
Published: March 06, 2025
5-α Reductase Inhibitors and Prostate Cancer Mortality.
Journal: JAMA network open
Published: August 27, 2024
Long-term Relapse and Survival in Clinical Stage I Testicular Teratoma.
Journal: European urology focus
Published: August 08, 2024
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study.
Journal: European urology focus
Published: July 06, 2024
Statin use and oncological outcomes in a propensity-matched cohort of nonmetastatic castration resistant prostate cancer patients of the ARAMIS trial.
Journal: Urologic oncology
Published: May 28, 2024
Last Updated: 09/26/2026